BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 17968338)

  • 21. Nutritional and metabolic issues in inflammatory bowel disease.
    Cabré E; Gassull MA
    Curr Opin Clin Nutr Metab Care; 2003 Sep; 6(5):569-76. PubMed ID: 12913675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel therapeutic options in the inflammatory bowel disease world.
    Noble A; Baldassano R; Mamula P
    Dig Liver Dis; 2008 Jan; 40(1):22-31. PubMed ID: 17988966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms.
    De Schepper HU; De Man JG; Moreels TG; Pelckmans PA; De Winter BY
    Aliment Pharmacol Ther; 2008 Apr; 27(8):621-37. PubMed ID: 18221407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate immunity in inflammatory bowel disease: state of the art.
    Hisamatsu T; Ogata H; Hibi T
    Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The intimate relationship between gut and joint in spondyloarthropathies.
    Jacques P; Mielants H; Coppieters K; De Vos M; Elewaut D
    Curr Opin Rheumatol; 2007 Jul; 19(4):353-7. PubMed ID: 17551365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Joint involvement in chronic inflammatory bowel disease--current diagnostics and treatment options].
    Becker H; Gaubitz M; Domschke W; Kucharzik T
    Z Gastroenterol; 2006 Jun; 44(6):497-502. PubMed ID: 16773516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promotion of a favorable gut flora in inflammatory bowel disease.
    Kennedy RJ; Kirk SJ; Gardiner KR
    JPEN J Parenter Enteral Nutr; 2000; 24(3):189-95. PubMed ID: 10850949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotics: do they help to control intestinal inflammation?
    Böhm SK; Kruis W
    Ann N Y Acad Sci; 2006 Aug; 1072():339-50. PubMed ID: 17057214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spondylo-arthropathies.
    Handa R
    J Indian Med Assoc; 2003 Sep; 101(9):514, 516, 518. PubMed ID: 15168985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in inflammatory bowel disease.
    Singleton JW
    Chin J Dig Dis; 2005; 6(2):59-61. PubMed ID: 15904422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving knowledge and therapy of inflammatory bowel disease.
    Korzenik JR; Podolsky DK
    Nat Rev Drug Discov; 2006 Mar; 5(3):197-209. PubMed ID: 16518373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New knowledge on the pathogenesis of chronic inflammatory bowel diseases: what have we learned from colitis animal models?].
    Seibold F; Egger B; Göke B
    Schweiz Med Wochenschr; 2000 May; 130(20):749-55. PubMed ID: 10920852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do probiotics have a role in the management of inflammatory bowel disease?
    Morris JD; Diamond KA; Balart LA
    J La State Med Soc; 2009; 161(3):155-9. PubMed ID: 19772038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacotherapy for spondyloarthropathies].
    Babić-Naglić D
    Reumatizam; 2004; 51(2):22-8. PubMed ID: 15554373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint involvement in inflammatory bowel disease: managing inflammation outside the digestive system.
    De Vos M
    Expert Rev Gastroenterol Hepatol; 2010 Feb; 4(1):81-9. PubMed ID: 20136591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory bowel disease. 2. Current and future therapeutic options.
    Moses PL; Moore BR; Ferrentino N; Bensen SP; Vecchio JA
    Postgrad Med; 1998 May; 103(5):86-90, 95-7, 101-2. PubMed ID: 9590988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research and clinical challenges in paediatric inflammatory bowel disease.
    Bousvaros A; Morley-Fletcher A; Pensabene L; Cucchiara S
    Dig Liver Dis; 2008 Jan; 40(1):32-8. PubMed ID: 17996504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?
    Singh S; Graff LA; Bernstein CN
    Am J Gastroenterol; 2009 May; 104(5):1298-313; quiz 1314. PubMed ID: 19337242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.